Both in Pharmaceuticals
Neuphoria Therapeutics vs Citius Pharmaceuticals
Over the past year NEUP returned −29.4% and CTXR returned −59.5%; their daily moves had a correlation of 0.12.
NEUP −29.4% CTXR −59.5%Growth of $1, one year, split-adjusted
| Metric | NEUP | CTXR |
|---|---|---|
| Price | $2.98 | $0.5510 |
| Market cap | $16.1M | $15.1M |
| Today | −0.33% | −3.87% |
| 1 month | −13.6% | +14.6% |
| 6 months | −44.6% | −17.3% |
| Year to date | −23.2% | −29.1% |
| 1 year | −32.0% | −63.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 67.1% |
| Net margin | — | −593.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.1× |
| Net cash | — | $10.6M |
| Dividend yield | — | — |
| Volatility (60d) | 27.6% | 96.0% |
| Short % of float | 0.1% | 21.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).